Literature DB >> 7846906

Basic study on hepatic resection under partial perfusion cooling.

I Hamamoto1, M A Hossain, S Okada, H Wakabayashi, T Maeba, S Tanaka.   

Abstract

To improve liver quality after reperfusion following partial hepatectomy under total or partial cooling of the liver (HPC), a new perfusion solution containing 100 mM L-histidine (KM solution) was developed. The livers of Lewis rats were removed and perfused for 2 hours at 20 degrees C with lactated Ringer's (LR) solution (group A) or the KM solution (group B). They were reperfused with rat blood at 37 degrees C at a perfusion pressure of 5 cmH2O while monitoring the portal and peripheral tissue blood flows. At the end of reperfusion, bile production, lactate dehydrogenase (LDH) secretion, and tissue adenosine triphosphate (ATP) was measured. Recovery of portal and peripheral tissue blood flows of the group B livers after reperfusion were significantly better than those of group A. Viability of the group B livers, assessed by bile production, tissue ATP value, and LDH release, was preserved better than that of group A livers. In situ total liver perfusion with LR (group C) and KM (group D) solutions for 1 hour at 20 degrees C followed by partial hepatectomy of the left lateral lobe was performed. The 1-week survivals of the group C and D rats were 25% and 100%, respectively (p < 0.05). It was concluded that KM solution is suitable for HPC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846906     DOI: 10.1007/bf00299081

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  An improved technique for isolated perfusion of rat livers and an evaluation of perfusates.

Authors:  H J Mischinger; T R Walsh; T Liu; P N Rao; R Rubin; K Nakamura; S Todo; T E Starzl
Journal:  J Surg Res       Date:  1992-08       Impact factor: 2.192

2.  Extended cold preservation time (20 hours 20 minutes) of a human liver graft by using cardioplegic HTK solution.

Authors:  G Gubernatis; K H Dietl; J Kemnitz; K Oldhafer; J Hauss; B Buchholz; R Pichlmayr
Journal:  Transplant Proc       Date:  1991-10       Impact factor: 1.066

3.  HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences.

Authors:  G Gubernatis; R Pichlmayr; P Lamesch; H Grosse; A Bornscheuer; H J Meyer; B Ringe; M Farle; H J Bretschneider
Journal:  Langenbecks Arch Chir       Date:  1990

4.  Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases.

Authors:  E Delva; Y Camus; B Nordlinger; L Hannoun; R Parc; H Deriaz; A Lienhart; C Huguet
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

5.  An improved technic for vascular isolation of the liver: experimental study and case reports.

Authors:  J P Heaney; W K Stanton; D S Halbert; J Seidel; T Vice
Journal:  Ann Surg       Date:  1966-02       Impact factor: 12.969

6.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury.

Authors:  K R Chien; J Abrams; A Serroni; J T Martin; J L Farber
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

7.  Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation.

Authors:  M B Grisham; L A Hernandez; D N Granger
Journal:  Am J Physiol       Date:  1989-11

8.  Major hepatic resection using vascular isolation and hypothermic perfusion.

Authors:  J G Fortner; M H Shiu; D W Kinne; D K Kim; E B Castro; R C Watson; W S Howland; E J Beattie
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

9.  72-hour preservation of the canine pancreas.

Authors:  J A Wahlberg; R Love; L Landegaard; J H Southard; F O Belzer
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

10.  Rat liver lipids during ex vivo warm and cold ischemia and reperfusion.

Authors:  I Hamamoto; E M Nemoto; R W Evans; H J Mischinger; S Fujita; N Murase; S Todo
Journal:  J Surg Res       Date:  1993-10       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.